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BACKGROUND: In the early stages of human placentation, the decidua is invaded by fetal extravillous trophoblast
(EVT) cells. Interactions between EVT cells and local decidual leukocytes are likely to contribute to immunological
accommodation of the semi-allogeneic fetus. METHODS AND RESULTS: Natural-killer group 2 member D
(NKG2D) and 2B4 (CD244) are receptors ubiquitously expressed by the distinctive population of CD56 bright,
uterine natural-killer cells, which dominate the decidua at the time of implantation. Here, we investigate the UL-16
binding protein (ULBP) and MHC class-I chain related molecule (MIC) ligands of NKG2D, the CD48 ligand of
2B4 and the non-classical HLA class-I molecule, HLA-F, at the maternal–fetal interface of normal pregnancies.
For many of these molecules, signiﬁcant mRNA expression was detected by RT-PCR in decidual and placental
tissue throughout gestation. Flow cytometry of isolated cells or immunohistological staining of implantation site sec-
tions was then performed. No protein expression of NKG2D ligands or HLA-F could be detected in decidual leuko-
cytes or fetal trophoblast cells from the ﬁrst trimester. An NKG2D-Fc fusion protein identiﬁed no novel ligands for
this promiscuous receptor at the maternal–fetal interface. Strong surface protein expression of CD48 by decidual leu-
kocytes but not by trophoblast cells was detected by ﬂow cytometry. Histological staining showed a clear aggregation
of CD48
1 cells around transformed spiral arteries of the implantation site. CONCLUSIONS: We conclude that the
role of NKG2D and 2B4 is not focussed on trophoblast recognition in normal pregnancy, but is more likely involved
in cross-talk among maternal cells of the placental bed.
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Introduction
Placentation in humans is a complex process in which invading
extravillous trophoblast (EVT) cells move through the decidua
to transform spiral arteries and establish an increased blood
supply to the fetus (Moffett and Loke, 2006). EVT cells
display an unusual array of HLA class-I (HLA-I) molecules:
HLA-C, HLA-E and HLA-G (King et al., 2000; Apps et al.,
2007, 2008). As they migrate through the uterine wall, EVT
cells come into close contact with maternal decidual leukocytes
composed mainly of natural-killer (NK) cells and macrophages
with a small population of T cells. The dominant decidual leu-
kocytes at the time of implantation are a distinctive population
of uterine NK (uNK) cells that have a phenotype and function
distinct from cells in peripheral blood (Moffett-King, 2002).
There is growing evidence that uNK cells play a crucial role
in regulating the degree of trophoblast invasion and therefore
maternal blood ﬂow to the placenta and developing fetus
(Hiby et al., 2004; Hanna et al., 2006). uNK cells have killer
cell immunoglobulin-like receptors (KIR), leukocyte
immunoglobulin-like receptors (LILR) and CD94/NKG2
family receptors capable of recognizing all three trophoblast
HLA-I molecules (King et al., 2000; Apps et al., 2007;
Sharkey et al., 2008). uNK also express additional activating
and inhibitory receptors including NK group 2 member D
(NKG2D) and 2B4 (CD244) whose potential interactions
with trophoblast ligands have not been explored (Hanna
et al., 2006; Vacca et al., 2006; Zhang et al., 2007).
NKG2D is a C-type lectin-like molecule that is an activating
receptor expressed by NK cells and T cell subsets (Raulet,
2003). Unlike many NK receptors, the ligands for NKG2D
(NKG2DL) are diverse and numerous. In humans there are two
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Advance Access publication on July 24, 2008families structurally related to HLA-I molecules: MHC class-I
related (MIC) and UL-16 binding proteins (ULBP) (Eagle and
Trowsdale,2007).CertainNKG2DLsareconstitutivelyexpressed
by cells at high risk of infection, such as the gut epithelium
(Groh et al., 1996). NKG2DL expression can be induced in
other tissues by stresses such as infection or transformation
(Groh et al., 2001; Gasser et al., 2005). EVT cells are of extra-
embryonic origin and express epithelial cell markers. By virtue
of their endogenous retroviral expression and invasive behaviour,
they also have similarities to infected and tumour cells. In
addition, NKG2DLs have been found to be expressed by leuko-
cytes such as activated antigen-presenting cells and provide a
mechanism of interaction with NK cells (Draghi et al., 2007).
2B4 (CD244) is a receptor from the family of signalling
lymphocyte-activation molecules (SLAM) which encode a ligand
binding immunoglobulin (Ig)V domain distal to a single IgC2
domain (Ma et al., 2007). 2B4 is expressed by NK cells and
T cell subsets (Valiante and Trinchieri, 1993) and binds CD48
(Brown et al., 1998), a glycosylphosphatidylinositol-linked
CD2-related molecule expressed widely on haematopoietic
cells but not investigated in the decidua (Korı ´nek et al., 1991;
Yokoyama et al., 1991). Although 2B4–CD48 interactions
inﬂuence activation of leukocyte effector function, the outcomes
are not clearly understood. In human NK cells, 2B4 can activate
cytotoxicity and interferon (IFN)-g production through SLAM-
associated protein (SAP), an SH2 domain-containing adaptor
molecule which results in severe immunodeﬁciency when
defective (Tangye et al., 2000). In contrast, in the absence
of SAP, 2B4 delivers inhibitory signals in murine and human
NK cells (Parolini et al., 2000; Lee et al., 2004).
Trophoblast cells may express additional molecules, which
are potential ligands for NK cell receptors. HLA-F is a non-
classical HLA-I molecule with a restricted distribution of tissue
expression (Lepin et al., 2000). Endoplasmic reticulum export
trafﬁckingisdistinctfromotherHLA-Imoleculesbutnospeciﬁc
functions are known (Boyle et al., 2006). Existing studies with
the ﬁrst widely available anti-HLA-F monoclonal antibody
(mAb), 3D11, produced conﬂicting results regarding surface
or intracellular HLA-F expression by trophoblast cells (Ishitani
et al., 2003; Nagamatsu et al., 2006; Shobu et al., 2006).
Therefore, the NKG2D and 2B4 receptors expressed by
uNK cells could bind ligands on EVT cells and inﬂuence
NK cell function. We have now investigated the expression
of NKG2DLs, CD48 and HLA-F on normal trophoblast and
also on maternal cells present in the placental bed.
Materials and Methods
Cell lines and primary tissue
B lymphoblastoid 721 221 cells and the same line transfected with
HLA-F were obtained from Dr N. Holmes (Lury et al., 1990). U373
cells and the same line transfected with MICB were obtained from
Dr H. Reyburn (Vale ´s-Go ´mez et al., 2006). HLA-I negative African
Green Monkey CV-1 cells, human choriocarcinoma cell lines JEG-3
and JAR, as well as 293T, Jurkat, HT1080, H9 and Hela cell lines
were all purchased from the American Type Culture Collection
(ATCC reference numbers CCL-70, HTB-36, HTB-144,
CRL-11268, TIB-152, CCL-121, HTB-176 and CCL-2, respectively).
Using the primers shown (forward, reverse) extracellular regions of the
ULBP1 (50-TATAAGCTTGGCTGGTCCCGGGCA-30,5 0-CTCGAA
TTCTCATCTGCCAGCTAG-30), ULBP3 (50-TATAAGCTTTTCG
ACTGGTCCGGG-30,5 0-GATGAATTCTCAGATGCCAGGGAG-30)
and MICA (50-TATAAGCTTCCCCACAGTCTTCGT-30,5 0-TATG
AATTCCTGGACCCTCTGCAG-30) genes were each cloned into a
mammalian expression vector p3xFLAG-CMV-9 (Sigma–Aldrich).
A similar ULBP2 fragment in this vector was obtained from Bacon
et al. (2004). CV-1 cells were individually transfected with these
NKG2DL constructs using Lipofectamine 2000 (Invitrogen). Sequen-
cing of the newly constructed plasmids used for these transfectants
matched the Genebank sequences of accession numbers AB052907
(ULBP1), AB052908 (ULBP3) and L14848 (MICA) between the
regions deﬁned by the primers above.
Decidual and placental tissue was obtained at term or from elective
terminations of normal pregnancies between 6 and 12 weeks gestation.
Ethical approval for the use of these tissues was obtained from
the Cambridge Local Research Ethics Committee. Decidual leuko-
cytes and trophoblast cells were isolated as previously described
(Trundley et al., 2006). Brieﬂy, decidual tissue was disaggregated
with collagenase and mononuclear cells puriﬁed on Lymphoprep.
Trophoblast was released from chorionic villi by trypsin digestion
and macrophages were depleted by adherence to plastic. Freshly
isolated cells are predominantly of a villous trophoblast (VT) pheno-
type. After culture overnight on ﬁbronectin, 50–80% of the cells
become HLA-G
þ, characteristic of EVT cells.
mAbs and fusion proteins
mAbs to ULBP, MIC, HLA-F and CD48 molecules are detailed in
Table I. A mAb to NKG2D (M585) was also obtained from Cosman
et al. (2001) (Amgen Inc.). Well-established mAbs to HLA-DR
(L243), HLA-I (W6/32), 2B4 (C1.7), cytokeratin (MNF116) and the
Flag epitope (M2) were purchased from Becton Dickinson, Serotec,
Beckman Coulter, Dako and Sigma–Aldrich, respectively. Isotype
control IgG1, IgG2a, IgG2b, IgG3 and IgM mAbs were obtained from
Oxford Biotechnology or BD Pharmingen. Binding of all these
unlabelled mAbs was detected by phycoerythrin (PE)-conjugated
secondary reagents to IgG (Sigma–Aldrich) or total mouse Ig (Dako).
Conjugated mAbs used were CD3- ﬂuorescein isothiocyanate (FITC)
(SK7), CD14-FITC (MfP9), HLA-DR-FITC (L243), CD56-Alexa 488
(B159), LILRB3-PE-Cy5 (ZM3.8), and control IgG1- or IgG2a-FITC
(all BD Biosciences); HLA-G-FITC (clone G233 developed in our own
laboratory (Loke et al., 1997) or clone MEM-G/9 from Abcam) and
epidermal growth factor receptor (EGF-R)-FITC (EGFR1) from Insight
Biotechnology. A sequenced NKG2D-IgG Fc fusion protein construct
in the mammalian expression vector pcDNA3, obtained from Dr
H. Reyburn (Vale ´s-Go ´mez et al., 2003), was transiently transfected
into 293T cells using Lipofectamine 2000 (Invitrogen). Fusion protein
produced was quantiﬁed by Easy-Titer (Pierce) and in reducing sodium
dodecyl sulphate polyacrylamide gel electrophoresis resolved as a
single band at  70 kDa. Binding of this fusion protein was detected by
a PE-conjugated anti-human IgG secondary antibody (Sigma–Aldrich).
RT-PCR
Fragments of decidual or placental tissue were stored at –808C before
total RNA isolation (Qiagen RNAeasy), DNA digestion (Qiagen
DNase) and complementary DNA (cDNA) synthesis (Invitrogen
Superscript II) following the manufacturers instructions. For each
RT-PCR 50 ng of cDNA, 0.5 mM primers (Sigma–Genosys),
200 mM dNTP (Roche), between 2 and 3 mM magnesium chloride
and 0.6 U of Amplitaq Gold DNA polymerase with its potassium
chloride buffer (Applied Biosystems) were incubated on a Peltier
Thermal Cycler. After an initial incubation at 958C for 8 min, cycles
of 958C for 25 s, 50–708C for 45 s and 728C for 30 s were repeated
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electrophoresis (1% agarose in TBE (10 mM Tris (pH 7.4) and 1 mM
EDTA (pH 8) in dH20), with 0.5 mg/ml ethidium bromide (Sigma–
Aldrich)) and a 1 kb reference ladder (Invitrogen). Gels were visual-
ized using a FluorChem 9900 UV imaging system.
RT-PCR conditions were optimized to distinguish between
NKG2DLs and HLA-I molecules of up to 97% nucleotide sequence
identity. The primers and reaction conditions are detailed in
Table II, those for MIC ampliﬁcation were based on Welte et al.
(2003). Primer pairs span intronic sequences to avoid ampliﬁcation
of genomic DNA. To conﬁrm speciﬁc detection of the intended
gene, several PCR products from selected ampliﬁcation reactions
were cloned into pCR4-TOPO vectors and DH5a E. Coli transformed
using the TOPO cloning system (Invitrogen). Plasmids were extracted
(Qiagen Miniprep) and sequencing using T7 (50-TAATACGACT-
CACTATAGGG-30) and M13R (50-CAGGAAACAGCTATGAC-30)
primers. At least four PCR products from two or more tissues were
sequenced for each of the NKG2DLs and HLA-I genes investigated.
All of the 50 PCR products sequenced were the intended target.
Flow cytometry
Flow cytometry conditions to detect NKG2DLs for which transcripts
had been found were established using U373 cells stably expressing
MICB, or ULBP1-3 and MICA expressed in HLA-I negative CV-1
cells (Table I). Staining of the ﬂag epitope is included to indicate
transfection efﬁciencies. For staining of primary cells, ﬁrst Fcg
receptors were blocked by incubating with human IgG (Sigma–
Aldrich). Unlabelled antibodies or fusion protein was added and
detected with ﬂuorochrome-conjugated secondary reagents.
In blocking experiments, fusion protein was incubated with
anti-NKG2D (M585) or isotype control antibody prior to staining.
Free secondary antibody binding sites were blocked with the appropri-
ate species Ig, before staining with directly conjugated mAb to ident-
ify each leukocyte or trophoblast cell population. VTs are HLA-I
negative but are identiﬁed as the only cells in our trophoblast prep-
arations to express EGF-R (Jokhi et al., 1994). EVT cells are the
only cell type conﬁrmed to express the non-classical HLA-G mol-
ecule, which is recognized speciﬁcally by our mAb G233 (Loke
et al., 1997). Cells were analysed using a FACscan ﬂow cytometer
and CellQuest software (Becton Dickinson).
Immunohistochemistry
Acetone-ﬁxed, frozen sections of human tissue or smears of cultured
cells were blocked by incubating with serum of the species in which
the secondary antibody was raised. Primary antibodies described
above, were detected with biotinylated secondaries and streptavidin–
horse–radish peroxidase (both Vector Laboratories) and developed
with diaminobenzidine substrate (Sigma–Aldrich) as previously
described (Jokhiet al.,1993).Sections werecounterstained inCarazzi’s
haematoxylin and mounted with glycerol/gelatin. For double staining,
Table II. Primers and PCR conditions for gene expression analysis.
Target
transcript
Forward primer Reverse primer Amplicon
size (bp)
Annealing
temperature
(8C)
[MgCl2]
(mM)
Number of
cycles
Positive
control
cell line
ULBP1 50-GATGGGTCGACACACACTG-30 50-AGAGGGTGGTTTTGTTGGA-30 560 64 2.5 30 Jurkat
ULBP2 50-GCTACCAAGATCCTTCTGT-30 50-GTCAAAGAGGAGGAAGAACTGC-30 441 62 3.0 30 Jurkat
ULBP3 50-GCGATTCTTCCGTACCTGCTA-30 50-TGGTGGCTATGGCTTTGGGTT-30 640 67 2.0 30 HT1080
ULBP4 50-TATCCCTGACTTCTAGCCCT-30 50-GCCACTCACCATTTTGCCAC-30 749 60 2.5 33 HT1080
RAET1G 50-AGCCCCGCGTTCCTTCTA-30 50-TGTATACAAGGCAAGAGGGC-30 935 54 3.0 30 HT1080
RAET1L 50-CGCCATCCCAGCTTTG-30 50-TCAGATGCCAGGGAGGAT-30 730 58 2.0 35 Hela
MICA 50-CCTTGGCCATGAACGTCAGG-30 50-CCTCTGAGGCCTCRCTGCG-30 177 60 2.0 33 HT1080
MICB 50-ACCTTGGCTATGAACGTCACA-30 50-CCCTCTGAGACCTCGCTGCA-30 179 60 3.0 33 Jurkat
HLA-G 50-GACTCGGCGTGTCCGAGGAT-30 50-GACCGCAGCTCCAGTGACT-30 795 56 2.0 30 JEG-3
HLA-F 50-GTGGCCCTGAGGAACCTG-30 50-TGAGAGTAGCTCCCTCTGTTTCT-30 740 60 2.5 33 H9
GAPDH 50-ACCACAGTCCATGCCATCAC-30 50-TCCACCACCCTGTTGCTGTA-30  450 56 2.5 30 any
R in a primer sequence indicates a mixture of A or G nucleotides in a ratio of approximately 1:1. GAPDH, glyceraldehyde 3-phosphate dehydrogenase. RAET1,
retinoic acid early transcript 1.
Table I. Monoclonal antibodies used to investigate expression of potential natural-killer cell ligands.
Antigen Clone
name
Experimental conditions Source Reference for
production and
characterization Flow cytometry Immunohistochemistry
ULBP1 M295 12 mg/ml 5 mg/ml Dr D. Cosman (Amgen) Cosman et al. (2001)
ULBP1 AUMO1 hybridoma supernatant diluted 1:3 hybridoma supernatant diluted 1:4 Dr A. Steinle Welte et al. (2003)
ULBP2 M311 12 mg/ml 5 mg/ml Dr D. Cosman (Amgen) Cosman et al. (2001)
ULBP2 BUMO1 hybridoma supernatant diluted 1:3 hybridoma supernatant diluted 1:4 Dr A. Steinle Welte et al. (2003)
ULBP3 M550 16 mg/ml 5 mg/ml Dr D. Cosman (Amgen) Cosman et al. (2001)
ULBP3 166510 8 mg/ml 5 mg/ml R&D Systems R&D datasheet
MICA M673 16 mg/ml 5 mg/ml Dr D. Cosman (Amgen) Cosman et al. (2001)
MICA AMO1 14 mg/ml 5 mg/ml Immatics Biotechnologies Welte et al. (2003)
MICB BMO1 hybridoma supernatant diluted 1:3 hybridoma supernatant diluted 1:4 Dr A. Steinle Welte et al. (2003)
MICB BMO2 hybridoma supernatant diluted 1:3 hybridoma supernatant diluted 1:4 Dr A. Steinle Welte et al. (2003)
HLA-F FG-1 15 mg/ml 5 mg/ml Dr E. Lepin Lepin et al. (2000)
CD48 Tu ¨145 14 mg/ml na BD Pharmingen Hadam (1989)
CD48 6.28 10 mg/ml 5 mg/ml Developmental Studies
Hybridoma Bank
Yokoyama et al. (1991)
ULBP, UL-16 binding protein; MIC, MHC class-I chain related.
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FastRed substrate (Sigma–Aldrich).
Results
The receptors NKG2D and 2B4 are expressed by decidual
leukocytes
Flow cytometry of decidual leukocytes isolated from normal ﬁrst
trimester pregnancies conﬁrmed expression of both NKG2D and
2B4 on all CD56
þ and around 50% of CD3
þ cells (Fig. 1). This
is consistent with previous reports for decidual leukocytes
(Hanna et al., 2006; Vacca et al., 2006; Zhang et al., 2007)
and the pattern of expression for these receptors in peripheral
blood (Valiante and Trinchieri, 1993; Raulet, 2003). Interest-
ingly, NKG2D labelled with a higher intensity on uNK than
peripheral blood NK cells from the same individual (data not
shown (DNS)) consistent with reported mRNA level expression
studies (Koopman et al., 2003).
Figure 1: Expression of NKG2D and 2B4 receptors by decidual leukocytes.
Freshly isolated ﬁrst-trimester decidual leukocytes from normal human pregnancies were stained for NKG2D (A–D) or 2B4 (CD244) (E–K),
with CD56
þ or CD3
þ cells identiﬁed by directly conjugated monoclonal antibody (mAb). For each dot plot, leukocytes were gated by scatter
properties (not shown). For traces G and K, the additional gates shown R2 (CD56
þ cells) or R3 (CD3
þ cells) were used to select NK and T lym-
phocytes, respectively. Broken traces represent isotype control and continuous traces the anti-2B4 mAb staining. These results are representative
of decidual leukocytes isolated from at least four individuals. FITC, ﬂuorescein isothiocyanate; A488, alexa ﬂuor 488.
Apps et al.
2538NKG2DL mRNA expression at the maternal–fetal interface
NKG2DL mRNA expression was investigated using RT-PCR
capable of discriminating between the closely related MIC
and ULBP family members. Samples of decidua and placental
tissue from normal pregnancies in their ﬁrst trimester and at
term were screened, as well as freshly isolated trophoblast
(which is predominantly villous) and isolated trophoblast
cells cultured overnight (which differentiate to an HLA-G
þ
extravillous phenotype (Trundley et al., 2006)) (Fig. 2).
Detection of glyceraldehyde 3-phosphate dehydrogenase and
HLA-G transcripts veriﬁes cDNA synthesis and conﬁrms the
presence of EVT cells, respectively. ULBP1 was detected in
each of the three cultured EVT cell preparations and ﬁrst
trimester placental samples as well as two of the three term
placental samples. In contrast, ULBP1 was not detected in
freshly isolated VT, decidua or peripheral blood mononuclear
cells (PBMC). ULBP2, MICA and MICB transcripts were
widespread in decidual, placental and trophoblast preparations.
ULBP3 was detected in all placental samples, but less
frequently in trophoblast. ULBP4 and retinoic acid early tran-
script (RAET) 1G expression was detected mainly in decidual
tissue. RAET1L was not detected in any primary tissue. Only
low levels of ULBP3 and MIC transcripts were detected in per-
ipheral blood. This rules out the possible detection of
expression in decidual samples as a result of contamination
by peripheral blood. ULBP1-3, MICA and MICB transcripts
were also detected in the JEG-3 choriocarcinoma cell line
(DNS). In summary, signiﬁcant mRNA expression of
ULBP1-3, MICA and MICB molecules was detected in tropho-
blast and decidual cells.
Surface protein expression of NKG2DL investigated
by ﬂow cytometry
We next investigated protein expression of ULBP1-3, MICA
and MICB on cells from the implantation site using ﬂow cyto-
metry. Individual transfectants were produced to establish the
ﬂow cytometry conditions for detection of each of these
NKG2DLs (Fig. 3A–C). Using these ﬂow cytometry con-
ditions, the choriocarcinoma cell lines JEG-3 and JAR were
initially tested. They only expressed ULBP1 surface protein
(Fig. 3D and E). Next, freshly isolated ﬁrst trimester tropho-
blast cells were analysed. Cells of villous and extravillous phe-
notype in our primary cell preparations were positively
identiﬁed by labelling for EGF-R and HLA-G, respectively
(Jokhi et al., 1994; Loke et al., 1997). Neither of these tropho-
blast sub-populations bound mAbs to ULBP1-3, MICA or
MICB (Fig. 3F and G). As a positive control for HLA-I-like
molecule staining, labelling was performed in parallel with
the mAb W6/32 (Parham et al., 1979). Shown at the bottom
of Fig. 3G, HLA-I negative VT remain in the lower right quad-
rant whereas EVT and stromal cells/leukocytes contaminating
our primary cell preparations stain with W6/32 in the upper
right and left quadrants, respectively.
Our isolation of primary trophoblast cells includes a trypsin
digestion to dissociate cells from chorionic villi (Trundley
et al., 2006). Exposure of transfected cell lines to similar
Figure 2: mRNA expression of NKG2D ligands and non-classical HLA-I genes at the human implantation site.
Triplicate samples of placental and decidual tissues were obtained at term, 11–12 and 6–7 weeks gestation from normal human pregnancies.
Trophoblast cells were also isolated from early placental samples (see Materials and Methods). cDNA from these tissues was screened by
RT-PCR for each NKG2DL, HLA-G and HLA-F. PCR products from each reaction were cloned, sequenced and in every case the intended tran-
script had been ampliﬁed. ULBP, UL-16 binding protein; MIC, MHC class-I chain related; GAPDH, glyceraldehyde 3- phosphate dehydrogenase;
RAET1, retinoic acid early transcript 1; PBMC, peripheral blood mononuclear cells.
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labelling of MIC and ULBP. This effect is not observed with
HLA-I molecules (DNS). We therefore analysed trophoblast
cells cultured overnight to check the possibility that surface
NKG2DLs might be reconstituted and then detected. In these
experiments, trophoblast cells were dissociated after culture
by a brief incubation with EDTA. Neither VT nor EVT cells,
identiﬁed by EGF-R and HLA-G labelling as before, bound
mAb to ULBP1-3, MICA or MICB (DNS). In other tissues,
surface expression of ULBP and MIC molecules is induced
or up-regulated by stress stimuli such as infection or DNA
damage (Groh et al., 2001; Gasser et al., 2005). We used the
stress stimuli of irradiation or toll-like receptor (TLR)
stimulation, but no induction of NKG2DL expression was
observed (DNS).
Another possibility is that NKG2D on uNK cells interacts
with its ligands on maternal decidual cells. For example,
antigen presenting cells have been reported to express
NKG2DLs when infected with inﬂuenza (Draghi et al.,
2007). Anti-NKG2DL mAbs showed no labelling of decidual
Figure 3: NKG2DL expression investigated by ﬂow cytometry.
(A–C) A panel of transfected cells was stained with isotype control mAb (A), anti-ﬂag mAb to indicate expression of tagged NKG2DL constructs
in CV-1 cells (B) and anti-NKG2DL mAb (C). The proportion of cells staining (positive) is indicated by the percentage shown in each plot. (D and
E) NKG2DL expression was investigated on the choriocarcinoma cell lines JEG-3 (D) and JAR (E). Binding of mAbs detecting each NKG2DL
(open traces) and an isotype control (ﬁlled traces) is shown. (F and G) NKG2DL expression by fetal trophoblast cells isolated from normal, ﬁrst
trimester pregnancies. EVT cells are identiﬁed by labelling HLA-G (F), and VT cells by staining EGF-R (G). No NKG2DL mAbs bound either
cell type, compared with an isotype control (top). Binding of the mAb W6/32 recognizing all HLA-I molecules is shown as a positive control
(bottom). (H) NKG2DL expression by maternal decidual macrophages isolated from normal, ﬁrst trimester pregnancies. Myelomonocytic
cells are identiﬁed by CD14 labelling, but no NKG2DL mAbs bind compared with an isotype control (top). Binding of HLA-DR (bottom) rep-
resents a positive control. Primary cells from at least 10 individuals were independently analysed, with no NKG2DL expression detected through-
out. Multiple mAbs for each NKG2DL are listed in Table I, the same binding patterns were observed with both mAbs to each NKG2DL
throughout our study.
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(AandB)Aspositivecontrols,acetoneﬁxedandfrozensmearsofcellsindividuallytransfectedwithULBP1-3,andMICAandMICBwerestained.
Representativelabellingwithanti-MICBmAbtoparent(A)andMICB-transfectedU373(B)cellsisshown.(C–F)Asectionofbreastcarcinomais
shownstainedwithisotypecontrolmAb(C),anti-MICAmAb(D)andforcytokeratinwhichisstronglypositive(E).Asectionofgastricmucosaalso
stains with mAb to MICA (F). (G–M) Serial sections of a normal human implantation site at 8 weeks gestation labelled with isotype control mAb
(G), anti-HLA-G mAb G233 to identify EVT cells (H), and mAb to ULBP1 (I), ULBP2 (J), ULBP3 (K), MICA (L) and MICB (M). No binding to
any cell type was detected in sections from three independent donors. A and B are at  400 magniﬁcation, C–M are  200.
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þ HLA-DR
þ myelomonocytic cells, or any other of the
cells identiﬁed by a cocktail of leukocyte lineage markers
either freshly isolated with collagenase or after overnight
culture (Fig. 3H and DNS). Stress stimuli were also investi-
gated as above but no inducible NKG2DL expression was
detected (DNS).
NKG2DL protein expression investigated by
immunohistochemistry
To avoid the difﬁculties of enzymic digestion stripping
NKG2DLs from the cell surface and to detect any intracellular
proteins present, we performed immunohistochemistry staining
of acetone-ﬁxed implantation site sections. The mAbs used
were able to detect their antigens in cytospin smears of trans-
fectants and on tissue sections of gastric mucosa and breast car-
cinoma (Fig. 4A–F) (Eagle and Trowsdale, 2007). Serial
sections of the implantation site (identiﬁed by HLA-G
þ
EVT) from a normal human pregnancy at 8 weeks gestation
were then screened for NKG2DL expression (Fig. 4G–N).
No labelling with mAbs to the ULBP1-3, MICA or MICB
molecules was observed by trophoblast or any other cells at
the implantation site.
Investigation of novel NKG2DLs with an NKG2D-Fc
fusion protein
As NKG2D is a promiscuous receptor with polygenic and
polymorphic ligands, it is possible that novel NKG2DLs are
present at the maternal–fetal interface. An NKG2D-Fc fusion
protein was used that speciﬁcally bound to MICB on trans-
fected cells (Fig. 5A) (Sutherland et al., 2002). No binding of
NKG2D-Fc was observed to freshly isolated or overnight
cultured HLA-G
þ or EGF-R
þ trophoblast cells (Fig. 5B–H
and DNS).
HLA-F expression at the maternal–fetal interface
There are conﬂicting reports about the expression of HLA-F on
trophoblast cells (Ishitani et al., 2003; Nagamatsu et al., 2006;
Shobu et al., 2006). Using RT-PCR, we detected HLA-F tran-
scripts in all decidua, placenta and trophoblast samples (Fig. 2).
We next used a new well-characterized mAb FG-1 to screen for
protein expression (Lepin et al., 2000). Using ﬂow cytometry
and immunohistochemistry, the mAb FG-1 was conﬁrmed to
detect HLA-F on transfected cells (Fig. 6A and DNS). No
HLA-F expression was detected on freshly isolated trophoblast
cells or decidual leukocytes by ﬂow cytometry (Fig. 6B–J). By
immunohistochemistry only very weak staining of FG-1 was
seen (Fig. 6K and L). The cells staining were not EVT, but
possibly uNK cells identiﬁed by labelling serial sections for
FG-1, HLA-G and CD56 (Fig. 6M–O). The weak staining
with mAb FG-1 was restricted to those uNK cells near the
site of trophoblast invasion.
CD48 is expressed by decidual cells at the maternal–fetal
interface
As all uNK cells express 2B4 (Fig. 1E–K), we investigated
expression of its ligand CD48 at the maternal–fetal interface
using two different mAbs, clones Tu ¨145 and 6.28. In ﬂow cyto-
metry, fetal HLA-DR
þ Hofbauer cells bound mAb Tu ¨145 but
not mAb 6.28, whereas HLA-G
þ extravillous or EGF-R
þ VT
cells did not bind either of the anti-CD48 mAbs (Fig. 7A–F).
In leukocytes isolated from the decidua, CD48 was strongly
detected on all CD3
þ T cells by both mAbs and CD56
þ cells
only by the mAb 6.28. HLA-DR
þ or LILRB3
þ myelomonocytic
cells in the decidua did not bind either CD48 mAb relative to
isotype controls (Fig. 7G–L and DNS). Histological staining
of normal ﬁrst trimester decidual sections with mAb 6.28
revealed striking aggregation of positive cells around modiﬁed
spiral arteries at the implantation site, which showed some
co-localizationwithCD56
þcellsindoublelabelling(Fig.7M–O).
Figure 5: No novel NKG2DLs are detected on human trophoblast
cells using an NKG2D-Fc fusion protein.
(A) An NKG2D-Fc fusion protein was produced by transient transfec-
tion of 293T cells and bound MICB-transfected U373 cells (black
trace), compared with control supernatant from 293T cells transfected
with an empty plasmid (ﬁlled trace) or ﬁrst incubation with a mAb to
NKG2D (grey trace). (B–H) NKG2D-Fc binding to freshly isolated
ﬁrst trimester trophoblast cells was tested. Antibodies directly conju-
gated to FITC were used compared with an isotype control (B), to
identify EVT cells by HLA-G labelling (C) or VT by EGF-R labelling
(D). These positive cells in C and D were gated for analysis of
NKG2D-Fc fusion protein binding (E–H). There was no binding to
either trophoblast population of the fusion protein (black trace) com-
pared with controls (ﬁlled traces) of an immunoglobulin G-Fc frag-
ment (E and G) or the mock supernatant (F and H) for three
independent donors.
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In this study, we analysed the expression of possible ligands
for NK receptors on cells at the maternal–fetal interface in
the ﬁrst trimester of pregnancy. The NKG2D receptor was
strongly expressed by all uNK cells and 50% of T cells, con-
sistent with increased NKG2D transcription in decidual
compared with peripheral NK cells (Koopman et al., 2003).
Although we found transcripts for several NKG2DLs in
tissues from the implantation site, no protein expression
was demonstrated by ﬂow cytometry or immunohistoche-
mistry on cells from normal pregnancy. Post-transcriptional
control of NKG2DL expression is not unusual. Indeed, MIC
Figure 6: Analysis of HLA-F expression at the ﬁrst trimester implantation site.
(A) mAb FG-1 binds HLA-F transfected (open trace) compared with parent .221 cells (ﬁlled trace). (B–D) This anti-HLA-F mAb shows no
binding to trophoblast cells isolated from normal ﬁrst trimester placenta, with EVT cells identiﬁed by labelling of HLA-G. (E–J) The anti-HLA-F
mAb FG-1 shows no binding to decidual leukocytes isolated from normal pregnancies. T lymphocytes (E–G) and NK cells (H–J) are identiﬁed by
labelling of CD3 andCD56, respectively.Primary cells from atleast 10 individualswere independently analysed byﬂow cytometry.(K–O) Serial
sections of a normal human implantation site at 8 weeks gestation were labelled with isotype control mAb (K), or anti-HLA-F mAb FG-1 (L)a t
 400 magniﬁcation. The same section is also shown stained (arrow) with FG-1 (M), anti-HLA-G mAb G233 (N) and anti-CD56 (O)a t 200
magniﬁcation. The immunohistochemistry ﬁgures shown are representative of staining observed in sections from three independent donors.
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expression is observed and induction of surface ULBP
protein expression by bronchial epithelial cells has been
shown to occur without protein synthesis (Borchers et al.,
2006). NKG2DLs are known to be up-regulated by various
stress stimuli but after treatment with irradiation or pathogen-
associated molecular pattern molecules no expression was
found on any cell type. In contrast, and in keeping with
their origin from malignant tumours, the choriocarcinoma
cell lines JEG-3 and JAR did express ULBP1 surface
protein. We also explored whether other, novel NKG2DLs
might be found on trophoblast by screening with an
NKG2D-Fc fusion protein but found no binding.
NKG2DLs may also be shed from infected or tumour cells
and can be detected in the blood of cancer patients (Salih
et al., 2002, 2006). Constitutive or soluble NKG2DL bind to
NKG2D and down-regulate its expression on NK and T cells,
abrogating NK activation towards the tumour or infected cell
(Doubrovina et al., 2003; Oppenheim et al., 2005; Wiemann
et al., 2005). A report that trophoblast cells produce soluble
MIC and in this way mediate maternal tolerance to the fetus
suggested a similar mechanism might operate in pregnancy
(Mincheva-Nilsson et al., 2006). In agreement with our
study, MIC mRNA was detected in trophoblast. MIC protein
expression was demonstrated using a different mAb to that
used in our study, E-16, but the speciﬁcity of this mAb has
Figure 6: Continued
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2544Figure 7: CD48 is expressed by decidual leukocytes but not fetal trophoblast cells.
(A–F) CD48 expression by fetal cells isolated from normal, ﬁrst trimester pregnancies. EVT cells are identiﬁed by HLA-G labelling (A and B),
VT cells by staining EGF-R (C and D) and myelomonocytic cells by HLA-DR expression (E and F). Binding of mAbs 6.28 and Tu ¨145, both
recognizing CD48, is shown relative to their respective controls. (G–L) CD48 expression by maternal decidual leukocytes isolated from
normal, ﬁrst trimester pregnancies. NK cells are identiﬁed by CD56 expression (G and H), T lymphocytes by CD3 staining (I and J) and mye-
lomonocytic cells by HLA-DR labelling (K and L). Binding of both mAbs 6.28 and Tu ¨145 recognizing CD48 is shown. Primary cells from at least
10 individuals were independently analysed by ﬂow cytometry with each mAb. (M–O) Immunohistochemical staining of a normal human
implantation site at 8 weeks gestation. Compared with an isotype control (M), anti-CD48 mAb 6.28 strongly stains decidual cells aggregated
around transformed spiral arteries of the implantation site (N)(  200 magniﬁcation). A double labelled decidual section at  400 magniﬁcation
shows some co-localization (arrows) of mAb 6.28 staining (brown), with CD56
þ cells (red). The immunohistochemistry ﬁgures shown are repre-
sentative of staining observed in sections from three independent donors.
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ments including blocking mAb to soluble MIC were
performed without isotype controls. It would seem highly
disadvantageous for a pregnant woman if the placenta was a
source of soluble NKG2DL with resulting impairment of her
systemic immune responses to tumours and infections. We
also explored the possibility that NKG2DLs could be expressed
by maternal cells in the decidua because following signalling
via TLR, NKG2DLs can be up-regulated on antigen-presenting
cells (Draghi et al., 2007). Macrophages and dendritic cells
are abundant at the implantation site but were not found to
express any NKG2DLs.
We can conclude that in normal pregnancies NKG2DL
proteins are not found on any maternal or fetal cell at the
implantation site. The situation might change in pathological
pregnancies. Although we tested induction with classical
stress stimuli such as TLR stimulation and irradiation, these
are unlikely to occur very often in the uterus during pregnancy.
Transplacental infections generally do not involve the decidua
as the pathogens (e.g. human immunodeﬁciency virus) cross to
the fetus via VT from maternal blood in the intervillous space.
NKG2DLs could be up-regulated in response to stresses of
pregnancy such as hypoxia or aneuploidy (Weier et al.,
2005). This could be a mechanism for maternal NK cells to
respond to abnormal concepti.
HLA-F is a non-classical HLA-I molecule with a restricted
distribution of expression that is mainly not at the cell
surface (Wainwright et al., 2000). The divergent trafﬁcking
of HLA-F suggests any functions of this molecule may be inde-
pendent of peptide presentation to T cells (Boyle et al., 2006).
HLA-F tetramers have been shown to bind LILRB1 and 2
which are both expressed by decidual leukocytes (Lepin
et al., 2000). Previous studies using trophoblast cells are
conﬂicting and have shown either intracellular or surface
expression using the mAb 3D11 (Ishitani et al., 2003;
Nagamatsu et al., 2006; Shobu et al., 2006). We used a
newly available mAb, FG-1, which is highly speciﬁc and of
high afﬁnity (Lepin et al., 2000). With this reagent weak stain-
ing was only found for maternal lymphoid cells, probably
CD56
þ NK cells. We could demonstrate no surface expression
of HLA-F by any cells at the implantation site by ﬂow cytome-
try and all trophoblast populations were also negative by
immunohistochemistry. Thus, at present, there is still only con-
vincing evidence that three HLA-I molecules are displayed by
human EVT cells: HLA-C, HLA-E and HLA-G (King et al.,
2000; Apps et al., 2007, 2008).
The last NK receptor investigated was 2B4 which was
detected on all NK cells and a subset of T cells, conﬁrming
previous reports using decidual and blood leukocytes (Vacca
et al., 2006; Ma et al., 2007). CD48, the ligand for both 2B4
and CD2 receptors, was not found to be expressed by tropho-
blast cells. We used two mAbs to CD48 and found different
patterns of binding for these reagents, a ﬁnding also observed
with PBMC (Korı ´nek et al., 1991; Yokoyama et al., 1991;
Lo et al., 1998; Morandi et al., 2005; Herna ´ndez-Campo
et al., 2006). In particular, all T cells bound both mAbs
to CD48, but CD56
þ NK cells bound only the mAb 6.28. In
sections, the cells binding anti-CD48 mAb were aggregated
around the spiral arteries that are the focus of trophoblast
invasion. These results suggest that CD48–2B4 interactions
Figure 7: Continued
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2546may occur in the vicinity of spiral arteries at the implantation site,
not with trophoblast cells but with other leukocytes. Interestingly,
2B4 ligation can inhibit cytoxicity and IFN-g production by
interleukin-2 stimulated uNK cells (Vacca et al., 2006).
Overall, we cannot ﬁnd evidence for protein expression of
ligands for the NK cell receptors NKG2D and 2B4 on
normal ﬁrst trimester trophoblast cells. Both of these receptors
are highly expressed by uNK cells and may function in patho-
logical pregnancies. For example, where concepti are affected
by karyotypic or other abnormalities, NKG2DLs might be
up-regulated and allow the mother to perceive and reject
implantation. In cases of intrauterine infection, NKG2DLs
may be induced on other maternal cells in the uterus such as
myelomonocytic, glandular or stromal cells and modulate
uNK cell function.
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